Status:
RECRUITING
Mosaic Trial for Stem Cell Transplant Recipients
Lead Sponsor:
Northwestern University
Collaborating Sponsors:
Georgetown University
Hackensack Meridian Health
Conditions:
Hematologic Malignancy
Stem Cell Transplant
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn if using an intervention website (Mosaic) improves selected patient-reported outcomes in adult blood cancer patients undergoing allogeneic or autologous ste...
Eligibility Criteria
Inclusion
- Diagnosed with a hematologic cancer according to medical records
- Scheduled for or preparing for scheduling of an allogeneic or autologous stem cell transplant at one of our study sites
- Aged 18 or older (no upper limit)
- English or Spanish Proficient
- Interested in using a website to learn about stem cell transplant
- Ability to understand and willingness to sign an informed consent document and comply with all study procedures
Exclusion
- Currently participating in a behavioral intervention targeting distress, health-related quality of life, or symptoms
- Undergoing the first in a planned tandem stem cell transplant
- Unable to provide meaningful consent (severe cognitive impairment or language difficulties)
Key Trial Info
Start Date :
April 28 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2030
Estimated Enrollment :
356 Patients enrolled
Trial Details
Trial ID
NCT06960993
Start Date
April 28 2025
End Date
February 1 2030
Last Update
July 18 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Georgetown University School of Medicine
Washington D.C., District of Columbia, United States, 20057
2
Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States, 60611
3
Hackensack Meridian Health
Nutley, New Jersey, United States, 07110